NCT03231982 - Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

May 31, 2019

Conditions

Hypertension

Interventions

DRUG

Group I

Machkhan Tab. 8/5 mg + Atacan Tab. 8 mg placebo + Norvasc Tab. 5 mg placebo for 8 weeks or Machkhan Tab. 16/5 mg + Atacan Tab. 16 mg placebo + Norvasc Tab. 5 mg placebo for 8 weeks

DRUG

Group II

Atacan Tab. 8 mg + Norvasc Tab. 5 mg + Machkhan Tab.8/5 mg placebo for 8 weeks or Atacan Tab. 16 mg + Norvasc Tab. 5 mg + Machkhan Tab.16/5 mg placebo for 8 weeks

Trial Locations (1)

Unknown

RECRUITING

Yonsei University Severance Cardiovascular Hospital, Seoul